Increased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome

Ping Yen Liu, Jyh Hong Chen, Li Jen Lin, James K. Liao

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Objectives: We sought to determine whether Rho kinase (ROCK) activity is increased in a Taiwanese population with metabolic syndrome (MetS). Background: Recent studies suggest that ROCK may be involved in the pathogenesis of MetS, but clinical studies linking ROCK with MetS are lacking. Methods: We studied 40 Taiwanese subjects (60% men, mean age 55.5 ± 5.6 years) who were diagnosed with MetS with National Cholesterol Educational Program Adult Treatment Panel III criteria and 40 age- and gender-matched control subjects. Subject demographics were recorded, and blood samples were obtained. Results: Compared with control subjects, ROCK activity, as determined by phosphorylation of myosin binding subunit (MBS) in leukocytes, was greater in MetS subjects (mean phospho-MBS/MBS ratio 0.46 vs. 0.35, p = 0.002). A cutoff value for ROCK activity of 0.39 predicted the presence of MetS with specificity and sensitivity rates of 70%. Plasma high-sensitivity C-reactive protein was greater (5.5 mg/l, 95% confidence interval [CI] 3.1 to 7.2 mg/l vs. 2.8 mg/l, 95% CI 1.1 to 3.9 mg/l, p = 0.01) and adiponectin was lower (4.9 μg/ml, 95% CI 3.2 to 6.1 μg/ml vs. 5.9 μg/ml, 95% CI 4.2 to 7.5 μg/ml, p = 0.01) in MetS subjects compared with control subjects, but plasma levels of interleukin-6 and tumor necrosis factor-alpha were not different (p > 0.05 for both). Body mass index, waist circumference, fasting glucose, high-sensitivity C-reactive protein, and triglyceride levels were associated with increased levels of ROCK activity. The risk of increased ROCK activity increased with the number of MetS components (p for trend <0.001). Conclusions: Rho kinase activity is increased in Taiwanese subjects with MetS and is associated with each component of MetS and markers of inflammation. These findings suggest that ROCK activity may be a novel serological marker of MetS.

Original languageEnglish
Pages (from-to)1619-1624
Number of pages6
JournalJournal of the American College of Cardiology
Volume49
Issue number15
DOIs
Publication statusPublished - 2007 Apr 17

Fingerprint

rho-Associated Kinases
Population
Myosins
Confidence Intervals
C-Reactive Protein
Adiponectin
Waist Circumference
Interleukin-6
Fasting
Triglycerides
Body Mass Index
Leukocytes
Tumor Necrosis Factor-alpha
Cholesterol
Phosphorylation
Demography

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Liu, Ping Yen ; Chen, Jyh Hong ; Lin, Li Jen ; Liao, James K. / Increased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome. In: Journal of the American College of Cardiology. 2007 ; Vol. 49, No. 15. pp. 1619-1624.
@article{32142e36156f421b8a6f47c1e9608f36,
title = "Increased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome",
abstract = "Objectives: We sought to determine whether Rho kinase (ROCK) activity is increased in a Taiwanese population with metabolic syndrome (MetS). Background: Recent studies suggest that ROCK may be involved in the pathogenesis of MetS, but clinical studies linking ROCK with MetS are lacking. Methods: We studied 40 Taiwanese subjects (60{\%} men, mean age 55.5 ± 5.6 years) who were diagnosed with MetS with National Cholesterol Educational Program Adult Treatment Panel III criteria and 40 age- and gender-matched control subjects. Subject demographics were recorded, and blood samples were obtained. Results: Compared with control subjects, ROCK activity, as determined by phosphorylation of myosin binding subunit (MBS) in leukocytes, was greater in MetS subjects (mean phospho-MBS/MBS ratio 0.46 vs. 0.35, p = 0.002). A cutoff value for ROCK activity of 0.39 predicted the presence of MetS with specificity and sensitivity rates of 70{\%}. Plasma high-sensitivity C-reactive protein was greater (5.5 mg/l, 95{\%} confidence interval [CI] 3.1 to 7.2 mg/l vs. 2.8 mg/l, 95{\%} CI 1.1 to 3.9 mg/l, p = 0.01) and adiponectin was lower (4.9 μg/ml, 95{\%} CI 3.2 to 6.1 μg/ml vs. 5.9 μg/ml, 95{\%} CI 4.2 to 7.5 μg/ml, p = 0.01) in MetS subjects compared with control subjects, but plasma levels of interleukin-6 and tumor necrosis factor-alpha were not different (p > 0.05 for both). Body mass index, waist circumference, fasting glucose, high-sensitivity C-reactive protein, and triglyceride levels were associated with increased levels of ROCK activity. The risk of increased ROCK activity increased with the number of MetS components (p for trend <0.001). Conclusions: Rho kinase activity is increased in Taiwanese subjects with MetS and is associated with each component of MetS and markers of inflammation. These findings suggest that ROCK activity may be a novel serological marker of MetS.",
author = "Liu, {Ping Yen} and Chen, {Jyh Hong} and Lin, {Li Jen} and Liao, {James K.}",
year = "2007",
month = "4",
day = "17",
doi = "10.1016/j.jacc.2006.12.043",
language = "English",
volume = "49",
pages = "1619--1624",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "15",

}

Increased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome. / Liu, Ping Yen; Chen, Jyh Hong; Lin, Li Jen; Liao, James K.

In: Journal of the American College of Cardiology, Vol. 49, No. 15, 17.04.2007, p. 1619-1624.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Increased Rho Kinase Activity in a Taiwanese Population With Metabolic Syndrome

AU - Liu, Ping Yen

AU - Chen, Jyh Hong

AU - Lin, Li Jen

AU - Liao, James K.

PY - 2007/4/17

Y1 - 2007/4/17

N2 - Objectives: We sought to determine whether Rho kinase (ROCK) activity is increased in a Taiwanese population with metabolic syndrome (MetS). Background: Recent studies suggest that ROCK may be involved in the pathogenesis of MetS, but clinical studies linking ROCK with MetS are lacking. Methods: We studied 40 Taiwanese subjects (60% men, mean age 55.5 ± 5.6 years) who were diagnosed with MetS with National Cholesterol Educational Program Adult Treatment Panel III criteria and 40 age- and gender-matched control subjects. Subject demographics were recorded, and blood samples were obtained. Results: Compared with control subjects, ROCK activity, as determined by phosphorylation of myosin binding subunit (MBS) in leukocytes, was greater in MetS subjects (mean phospho-MBS/MBS ratio 0.46 vs. 0.35, p = 0.002). A cutoff value for ROCK activity of 0.39 predicted the presence of MetS with specificity and sensitivity rates of 70%. Plasma high-sensitivity C-reactive protein was greater (5.5 mg/l, 95% confidence interval [CI] 3.1 to 7.2 mg/l vs. 2.8 mg/l, 95% CI 1.1 to 3.9 mg/l, p = 0.01) and adiponectin was lower (4.9 μg/ml, 95% CI 3.2 to 6.1 μg/ml vs. 5.9 μg/ml, 95% CI 4.2 to 7.5 μg/ml, p = 0.01) in MetS subjects compared with control subjects, but plasma levels of interleukin-6 and tumor necrosis factor-alpha were not different (p > 0.05 for both). Body mass index, waist circumference, fasting glucose, high-sensitivity C-reactive protein, and triglyceride levels were associated with increased levels of ROCK activity. The risk of increased ROCK activity increased with the number of MetS components (p for trend <0.001). Conclusions: Rho kinase activity is increased in Taiwanese subjects with MetS and is associated with each component of MetS and markers of inflammation. These findings suggest that ROCK activity may be a novel serological marker of MetS.

AB - Objectives: We sought to determine whether Rho kinase (ROCK) activity is increased in a Taiwanese population with metabolic syndrome (MetS). Background: Recent studies suggest that ROCK may be involved in the pathogenesis of MetS, but clinical studies linking ROCK with MetS are lacking. Methods: We studied 40 Taiwanese subjects (60% men, mean age 55.5 ± 5.6 years) who were diagnosed with MetS with National Cholesterol Educational Program Adult Treatment Panel III criteria and 40 age- and gender-matched control subjects. Subject demographics were recorded, and blood samples were obtained. Results: Compared with control subjects, ROCK activity, as determined by phosphorylation of myosin binding subunit (MBS) in leukocytes, was greater in MetS subjects (mean phospho-MBS/MBS ratio 0.46 vs. 0.35, p = 0.002). A cutoff value for ROCK activity of 0.39 predicted the presence of MetS with specificity and sensitivity rates of 70%. Plasma high-sensitivity C-reactive protein was greater (5.5 mg/l, 95% confidence interval [CI] 3.1 to 7.2 mg/l vs. 2.8 mg/l, 95% CI 1.1 to 3.9 mg/l, p = 0.01) and adiponectin was lower (4.9 μg/ml, 95% CI 3.2 to 6.1 μg/ml vs. 5.9 μg/ml, 95% CI 4.2 to 7.5 μg/ml, p = 0.01) in MetS subjects compared with control subjects, but plasma levels of interleukin-6 and tumor necrosis factor-alpha were not different (p > 0.05 for both). Body mass index, waist circumference, fasting glucose, high-sensitivity C-reactive protein, and triglyceride levels were associated with increased levels of ROCK activity. The risk of increased ROCK activity increased with the number of MetS components (p for trend <0.001). Conclusions: Rho kinase activity is increased in Taiwanese subjects with MetS and is associated with each component of MetS and markers of inflammation. These findings suggest that ROCK activity may be a novel serological marker of MetS.

UR - http://www.scopus.com/inward/record.url?scp=34047260912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047260912&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2006.12.043

DO - 10.1016/j.jacc.2006.12.043

M3 - Article

C2 - 17433952

AN - SCOPUS:34047260912

VL - 49

SP - 1619

EP - 1624

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 15

ER -